You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute myeloid leukemia

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia Trial in Beijing (Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte

Recruiting
  • Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • "3+7"
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Sep 29, 2023

Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Secondary Leukemia
  • Multiomic characterization
  • In vitro drug screening
  • (no location specified)
Aug 28, 2023

Acute Myeloid Leukemia Trial in Beijing, Tianjin (LCAR-AMDR Cells Product)

Recruiting
  • Acute Myeloid Leukemia
  • LCAR-AMDR Cells Product
  • Beijing, Beijing, China
  • +1 more
Jan 28, 2023

Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial (UAE Inhibitor TAK-243)

Not yet recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • UAE Inhibitor TAK-243
  • (no location specified)
Oct 20, 2022

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Vienna, Austria
  • +3 more
Jun 8, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 31, 2022

Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

Recruiting
  • Acute Myeloid Leukemia
  • Venclexta 100 MG Oral Tablet
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023

Leukemia, Myeloid, Acute Trial in Guangzhou, Hangzhou (BG1805)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • BG1805
  • Guangzhou, Guangdong, China
  • +2 more
Nov 1, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Cytokine-Induced Memory-like Natural Killer Cells
  • +2 more
  • Boston, Massachusetts
  • +1 more
Nov 22, 2023

Acute Myeloid Leukemia and Myelodysplastic Syndrome Trial in Tianjin (QLF32101)

Not yet recruiting
  • Acute Myeloid Leukemia and Myelodysplastic Syndrome
  • Tianjin, Tianjin, China
    Institute of Hematology&Blood Diseases Hospital,Chinese Academy
Jan 27, 2023

Relapsed/Refractory Acute Myeloid Leukemia Trial in Hefei (gdT cell injection targeting B7-H3 chimeric antigen receptor)

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • gdT cell injection targeting B7-H3 chimeric antigen receptor
  • Hefei, Anhui, China
    PersonGen Anke Cellular Therapeutice Co., Ltd.
Jan 31, 2023

Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in

Not yet recruiting
  • Acute Myeloid Leukemia
  • Genetic Predisposition to Disease
  • Collection of blood sample of bone marrow (cohort 1)
  • Collection of blood sample of bone marrow (cohort 2 and 3)
  • (no location specified)
Mar 6, 2023

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia Recurrent Trial in Beijing (CD123-CAR-NK cells)

Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia Recurrent
  • CD123-CAR-NK cells
  • Beijing, Beijing, China
    The Fifth Medical Center of Chinese People's Liberation Army (PL
Oct 24, 2022

Relapsed/Refractory Acute Myeloid Leukemia Trial in Beijing

Recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia
  • Azacytidine;Cytarabine;Aclacinomycin;Chidamide;Venetoclax;Granulocyte colony-stimulating factor
  • Best-Available Therapy(BAT) Regimen
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Oct 10, 2023

AML, Adult, Minimal Residual Disease Trial in Tianjin (CD33/CLL1 dual CAR-NK cell, Cyclophosphamid, Fludarabine)

Not yet recruiting
  • AML, Adult
  • Minimal Residual Disease
  • CD33/CLL1 dual CAR-NK cell
  • +5 more
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Aug 4, 2023

Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Suzhou, Jiangsu, China
  • +1 more
Jul 3, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Biospecimen Collection
  • +2 more
  • Orange, California
  • +9 more
Jan 27, 2023

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Baltimore, Buffalo (Gemtuzumab Ozogamicin,

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Gemtuzumab Ozogamicin
  • +4 more
  • Baltimore, Maryland
  • +1 more
Dec 13, 2022

Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Birmingham, Alabama
  • +2 more
Jan 3, 2023

Acute Myeloid Leukemia, MDS Trial in Rochester, Houston (CTX-712)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Rochester, Minnesota
  • +1 more
Feb 15, 2023

Relapsed/Refractory Acute Myeloid Leukemia (R/R AML) Trial in China (BL-M11D1)

Not yet recruiting
  • Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
  • Hefei, Anhui, China
  • +7 more
Jun 27, 2023

Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    Feb 2, 2023

    MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

    Not yet recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Subcutaneous azacitidine
    • Oral decitabine/cedazuridine
    • Newcastle, New South Wales, Australia
      Calvary Mater Newcastle
    May 29, 2023